Albert Cha's Net Worth
$NaN
Who is Albert Cha?
Albert Cha has an estimated net worth of $NaN. This is based on reported shares across multiple companies, which include BIOFORM MEDICAL INC, Biodel Inc, Biohaven Pharmaceutical Holding Co Ltd., Aclaris Therapeutics, Inc., KalVista Pharmaceuticals, Inc., ProNAi Therapeutics Inc, Menlo Therapeutics Inc., and Capnia, Inc..
SEC CIK
Albert Cha's CIK is 0001397906
Past Insider Trading and Trends
2014 was Albert Cha's most active year for acquiring shares with 31 total transactions. Albert Cha's most active month to acquire stocks was the month of October. 2015 was Albert Cha's most active year for disposing of shares, totalling 17 transactions. Albert Cha's most active month to dispose stocks was the month of October. 2018 saw Albert Cha paying a total of $20,000,000.50 for 1,156,551 shares, this is the most they've acquired in one year. In 2008 Albert Cha cashed out on 132,000 shares for a total of $2,046,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOFORM MEDICAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3,306.33% | 1.85M |
—
|
—
| 1.91M |
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biodel Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| -7.83% | -132.00K |
$15.50 | -$2,046,000.00 | 1.55M |
Feb 12
| |||
Form 4
| +177.84% | 1.08M |
—
|
—
| 1.69M |
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biohaven Pharmaceutical Holding Co Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +3.68% | 72.73K |
$27.50 | $1,999,992.50 | 2.05M |
Mar 14
| |||
Form 4
|
∞
| 1.98M |
$17.00 |
—
| 1.98M |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
| +1,282.36% | 3.89M |
$11.00 |
—
| 4.19M |
Oct 13
| |||
Form 4
| +4.61% | 13.35K |
$11.00 | $146,872.00 | 303.21K |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
|
—
|
0
|
$9.00 | -$54,230.40 |
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +11.31% | 115.69K |
$17.24 | $1,994,067.74 | 1.14M |
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
| +5.17% | 56.37K |
$16.99 | $957,737.10 | 1.15M |
Jul 26 - Jul 29
| |||
Form 4
| +5.95% | 61.28K |
$17.74 | $1,090,295.69 | 1.09M |
Jul 17 - Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
| +352.56% | 1.06M |
$17.00 | $18,000,008.00 | 1.36M |
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4/A
|
∞
| 4.2M |
$5.00 |
—
| 4.2M |
Apr 14
| |||
Form 4
|
∞
| 4.2M |
$5.00 |
—
| 4.2M |
Apr 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||